Fighting Cancer, One Cell At A Time.
Current clinically approved methods detect only Circulating Tumor Cells (CTC) of epithelial origin. Recent studies, however, demonstrate that tumor-derived Circulating Endothelial Cells (CEC) are superior biomarkers in cancer patients.
Our ApproachFinding the needle in the haystack
Get In Touch
Use the form below to contact us for more information.